These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26014804)

  • 1. Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.
    Tanner JA; Novalen M; Jatlow P; Huestis MA; Murphy SE; Kaprio J; Kankaanpää A; Galanti L; Stefan C; George TP; Benowitz NL; Lerman C; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1239-46. PubMed ID: 26014804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
    Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
    PLoS One; 2013; 8(8):e70938. PubMed ID: 23936477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
    Dempsey D; Tutka P; Jacob P; Allen F; Schoedel K; Tyndale RF; Benowitz NL
    Clin Pharmacol Ther; 2004 Jul; 76(1):64-72. PubMed ID: 15229465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum.
    Arger CA; Taghavi T; Heil SH; Skelly J; Tyndale RF; Higgins ST
    Nicotine Tob Res; 2019 Nov; 21(12):1706-1710. PubMed ID: 30165458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
    Levi M; Dempsey DA; Benowitz NL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):23-34. PubMed ID: 17206525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure.
    Matt GE; Quintana PJ; Liles S; Hovell MF; Zakarian JM; Jacob P; Benowitz NL
    Biomarkers; 2006; 11(6):507-23. PubMed ID: 17056471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies.
    Giratallah HK; Chenoweth MJ; Addo N; Ahluwalia JS; Cox LS; Lerman C; George TP; Benowitz NL; Tyndale RF
    Drug Alcohol Depend; 2021 Jun; 223():108708. PubMed ID: 33873029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate.
    Lea RA; Dickson S; Benowitz NL
    J Anal Toxicol; 2006; 30(6):386-9. PubMed ID: 16872570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.
    Nagano T; Shimizu M; Kiyotani K; Kamataki T; Takano R; Murayama N; Shono F; Yamazaki H
    Int J Environ Res Public Health; 2010 Jul; 7(7):2953-64. PubMed ID: 20717551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.
    Swan GE; Lessov-Schlaggar CN; Bergen AW; He Y; Tyndale RF; Benowitz NL
    Pharmacogenet Genomics; 2009 May; 19(5):388-98. PubMed ID: 19300303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
    Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of nicotine and its metabolites I. Model development.
    Levi M; Dempsey DA; Benowitz NL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):5-21. PubMed ID: 17206524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine.
    Taghavi T; Novalen M; Lerman C; George TP; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):882-891. PubMed ID: 29853480
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between cotinine and trans-3'-hydroxycotinine glucuronidation and the nicotine metabolite ratio in Caucasian smokers.
    Jacobson GA; Ferguson SG
    Biomarkers; 2014 Dec; 19(8):679-83. PubMed ID: 25373622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes.
    St Helen G; Jacob P; Benowitz NL
    Nicotine Tob Res; 2013 Nov; 15(11):1939-42. PubMed ID: 23674838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
    Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
    Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine Metabolites for Estimating Daily Intake of Nicotine From Cigarette Smoking.
    Benowitz NL; St Helen G; Nardone N; Cox LS; Jacob P
    Nicotine Tob Res; 2020 Feb; 22(2):288-292. PubMed ID: 30852610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Associations of
    Mahabee-Gittens EM; Matt GE; Jandarov RA; Merianos AL
    Int J Environ Res Public Health; 2023 Apr; 20(9):. PubMed ID: 37174159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.
    Jacob P; Yu L; Duan M; Ramos L; Yturralde O; Benowitz NL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):267-76. PubMed ID: 21208832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.
    Binnington MJ; Zhu AZ; Renner CC; Lanier AP; Hatsukami DK; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2012 Jun; 22(6):429-40. PubMed ID: 22569203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.